应用磁共振组织学进行精准慢性肢体威胁性缺血治疗规划
前瞻性纳入22例计划行经皮血管介入(PVI)的慢性肢体威胁性缺血患者,采用3T磁共振超短回波时间与稳态自由进动序列对40个目标病变进行组织学评分。磁共振评分为硬病变者即刻技术失败率及3、6个月再干预率均显著高于软病变,磁共振组织学可能有助于优化PVI患者选择。
要点
- 磁共振组织学将管腔狭窄>50%为硬成分的病变评为硬病变,硬病变即刻技术失败率为83%(5/6)。
- 磁共振硬评分是唯一与PVI即刻技术成功显著相关的因素(P<.001)。
- 磁共振硬病变在3个月和6个月再干预率均显著高于软病变。
核心结论
- 磁共振组织学可能是优化PVI患者选择和治疗策略的有价值工具。
研究设计与样本
- 前瞻性纳入22例(13例女性,平均年龄65.8±9.72岁)计划行PVI的患者,术前行3T磁共振超短回波时间与稳态自由进动序列检查。
- 由两名阅片者评估磁共振数据集,在显示硬成分最显著的横断面上,若管腔>50%被硬成分(钙化/致密胶原)占据则评为硬病变。
- 基于术中血管造影和病历回顾进行TASC/GLASS/WIfI评分,采用单变量分析探讨磁共振评分、TASC/GLASS评分与手术结局的关系。
- 术后3个月和6个月记录中期随访再血管化率和截肢率。
主要发现
- 22例患者共40个目标病变,排除5个(2个图像质量无法诊断,3个PVI最终仅用于诊断),6个病变(17%)评为硬病变。
- 磁共振硬病变即刻技术失败率高于软病变:硬病变83%(5/6)vs 软病变3%(1/29),P<.001。
- 磁共振硬评分是唯一与PVI即刻技术成功显著相关的因素(P<.001),而TASC/GLASS评分无此关联。
- 术后3个月再干预率硬病变80% vs 软病变16%(P=.011);术后6个月再干预率硬病变80% vs 软病变27%(P=.047)。
临床怎么用
- 原文结论认为磁共振组织学可能是优化PVI患者选择和治疗策略的有价值工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent randomized controlled trials have demonstrated a notable prevalence of immediate technical failures in percutaneous vascular interventions (PVIs) for complex arterial lesions associated with chronic limb-threatening ischemia. Current imaging modalities present inherent limitations in identifying these lesions, making it challenging to determine the most suitable candidates for PVI. We present a novel preprocedural magnetic resonance imaging (MRI) histology protocol for identifying lesions that might present a higher rate of immediate and midterm PVI failure. METHODS: We enrolled 22 patients (13 females, average age 65.8 ± 9.72 years) scheduled for PVI were prospectively and underwent 3T MRI using ultrashort echo time and steady-state free precession contrasts to characterize target lesions before PVI. Lesions were scored as hard if >50% of the lumen was occluded by hard components (calcium/dense collagen) on MRI in the hardest cross-section. Two readers evaluated MRI datasets. Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC)/Global Limb Anatomic Staging System (GLASS)/Wound, Ischemia and Foot infection scoring was performed based on intraprocedural angiograms and chart review. The relationship between MRI scoring, TASC/GLASS scoring, and procedural outcomes was investigated using univariate analysis. Midterm follow-up (revascularization and amputation rates) was recorded at 3 and 6 months after the intervention. RESULTS: Our cohort of 22 patients yielded 40 target lesions. Five lesions were excluded (two for nondiagnostic image quality; three PVIs were ultimately diagnostic only). Six lesions (17%) were scored as hard. MRI-scored hard lesions had a higher proportion of immediate technical failure (hard vs soft 83% [5/6] vs 3% [1/29]; P < .001). Hard vs soft MRI scoring was the only factor significantly associated with immediate PVI technical success (P < .001), as opposed to TASC/GLASS scoring. Both at 3 months and 6 months after PVI, the reintervention rate was significantly higher among those lesions which were scored hard on MRI (3 months hard, 80% vs soft, 16% [P =.011]; 6 months hard, 80% vs soft, 27%; P = .047). CONCLUSIONS: MRI histology could be a valuable tool for optimizing PVI patient selection and treatment strategies.
引用
- Csore J, Drake M, Karmonik C, et al. Employing magnetic resonance histology for precision chronic limb-threatening ischemia treatment planning. J Vasc Surg. 2024. PMID: 39218239. doi:10.1016/j.jvs.2024.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。